 Atea Pharmaceuticals AVIR stock is on the move Tuesday after providing an update from its Phase 2 Moonsong clinical trial update. The post AVIR Stock: The Oral Covid-19 Therapy News That Has Atea Pharmaceuticals Plunging Today appeared first on InvestorPlace. 